HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cristina Carreño Selected Research

1- (2- (2,5- diazabicyclo(2.2.1)hept- 2- yl)pyridin- 4- yl)- N- pyrazin- 2- yl- 1H- indazol- 3- amine

9/2015A novel inhaled Syk inhibitor blocks mast cell degranulation and early asthmatic response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cristina Carreño Research Topics

Disease

4Inflammation (Inflammations)
10/2019 - 10/2006
4Pain (Aches)
06/2012 - 04/2006
3Chronic Obstructive Pulmonary Disease (COPD)
10/2019 - 11/2009
2type 2C Congenital disorder of glycosylation
09/2015 - 04/2012
2Neuralgia (Stump Neuralgia)
06/2012 - 11/2003
1Onychomycosis (Tinea Unguium)
04/2022
1Erythema
04/2022
1COVID-19
02/2022
1Asthma (Bronchial Asthma)
10/2019
1Respiratory Tract Diseases (Respiratory Tract Disease)
10/2019
1Airway Remodeling
02/2014
1Pneumonia (Pneumonitis)
02/2014
1Osteosarcoma (Osteogenic Sarcoma)
06/2012
1Chronic Pain
10/2006
1Hyperalgesia
10/2006
1Alzheimer Disease (Alzheimer's Disease)
01/2002
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2002

Drug/Important Bio-Agent (IBA)

3Janus Kinase InhibitorsIBA
10/2019 - 01/2017
3Analgesics (Analgesic Drugs)IBA
06/2012 - 04/2006
2LipopolysaccharidesIBA
10/2019 - 01/2017
2aclidinium bromideIBA
02/2014 - 11/2009
2Muscarinic AntagonistsIBA
02/2014 - 11/2009
2Freund's AdjuvantIBA
06/2012 - 10/2006
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
11/2003 - 01/2002
1Terbinafine (Lamisil)FDA LinkGeneric
04/2022
1amorolfineIBA
04/2022
1SolutionsIBA
02/2022
1PurinonesIBA
10/2019
1Janus KinasesIBA
10/2019
1CytokinesIBA
10/2019
1OvalbuminIBA
01/2019
1AllergensIBA
01/2019
1tofacitinibIBA
01/2017
11- (2- (2,5- diazabicyclo(2.2.1)hept- 2- yl)pyridin- 4- yl)- N- pyrazin- 2- yl- 1H- indazol- 3- amineIBA
09/2015
1Bronchodilator Agents (Bronchodilators)IBA
02/2014
1SmokeIBA
02/2014
1Calcitonin Gene-Related PeptideIBA
06/2012
1palmitoyl- glutamyl- glutamyl- methionyl- glutaminyl- arginyl- argininamideIBA
06/2012
1Ion Channels (Ion Channel)IBA
06/2012
1Peptides (Polypeptides)IBA
06/2012
1Proteins (Proteins, Gene)FDA Link
06/2012
1Neurotransmitter Agents (Neurotransmitter)IBA
06/2012
1Syk KinaseIBA
04/2012
1AmidesIBA
04/2012
1TRPV Cation ChannelsIBA
11/2007
1CarrageenanIBA
10/2006
1Capsaicin (Zostrix)FDA Link
10/2006
1Irritants (Vesicants)IBA
10/2006
1Formaldehyde (Formol)FDA Link
10/2006
1(L- arginyl)- (N- (2,4- dichlorophenethyl)glycyl)- N- (2,4- dichlorophenethyl) glycinamideIBA
10/2006
1Glutamate Receptors (Glutamate Receptor)IBA
01/2002
1N-Methylaspartate (NMDA)IBA
01/2002
1Memantine (Namenda)FDA Link
01/2002

Therapy/Procedure

1Drug Therapy (Chemotherapy)
06/2012